Historical record - last NADAC effective date: 1/2/2020
Product Information
ACZONE 5% GEL is a brand product labeled by Allergan, Inc., priced at $9.6520 per GM under NDC 00023367090. Its NADAC has been published 373 times since Nov 28, 2013.
FDA first approved this application on Jul 7, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dapsone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/g
Manufacturer
Allergan, Inc.NDC
00023367090
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
1/2/2020
Active Ingredients
DAPSONEApproval Type
New Drug (NDA)
FDA Application
NDA021794FDA Approved
7/7/2005
TE Code
AB
On Market Since
6/24/2009
Pharmacological Classes
Price Statistics
The NADAC for ACZONE 5% GEL has been published 373 times since Nov 28, 2013, and over the history we have for it it has risen 66.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6520 per GM |
|---|---|
| All-time high | $9.6520 (Jan 13, 2021) |
| All-time low | $5.7970 (Nov 28, 2013) |
| Median price | $7.6260 |
| Average price | $7.7452 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 373 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+66.5%
Last surveyed Jan 13, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dapsone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACZONE 5% GEL?
The current National Average Drug Acquisition Cost (NADAC) for ACZONE 5% GEL, manufactured by Allergan, Inc., is $9.6520 per GM (NDC 00023367090), effective Jan 13, 2021.
How has the price of ACZONE 5% GEL changed over time?
Over the history we have for it, the NADAC for ACZONE 5% GEL has risen 66.5%. It has been tracked across 373 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACZONE 5% GEL?
Since Nov 28, 2013, the NADAC for ACZONE 5% GEL has ranged from a low of $5.7970 (Nov 28, 2013) to a high of $9.6520 (Jan 13, 2021), with a median of $7.6260 per GM.
Are there cheaper alternatives to ACZONE 5% GEL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPSONE 5% GEL, is $0.6638 per GM — about 93% below ACZONE 5% GEL.
Who manufactures ACZONE 5% GEL?
ACZONE 5% GEL (NDC 00023367090) is labeled by Allergan, Inc., and CMS classifies it as a brand product.